These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32384725)

  • 21. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
    Rios R; Sangro B; Herrero I; Quiroga J; Prieto J
    Am J Gastroenterol; 2005 Jun; 100(6):1311-6. PubMed ID: 15929762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
    Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence.
    Qureshi K; Patel S; Meillier A
    Int J Hepatol; 2016; 2016():1802932. PubMed ID: 27800187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management.
    Scharf RE
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia associated with chronic liver disease.
    Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
    J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.
    Rauber P; Lammert F; Grotemeyer K; Appenrodt B
    PLoS One; 2018; 13(2):e0192271. PubMed ID: 29438423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features.
    Zanetto A; Rinder HM; Campello E; Saggiorato G; Deng Y; Ciarleglio M; Wilson FP; Senzolo M; Gavasso S; Bulato C; Simioni P; Garcia-Tsao G
    Hepatology; 2020 Oct; 72(4):1327-1340. PubMed ID: 32614088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis.
    Kalambokis GN; Baltayiannis G; Christodoulou D
    World J Gastroenterol; 2016 May; 22(19):4786-8. PubMed ID: 27217711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.
    Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
    Thromb Res; 2015 Feb; 135(2):292-7. PubMed ID: 25434630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of serum levels of thrombopoietin to thrombocytopenia in extrahepatic portal vein obstruction versus cirrhotic children.
    El-Sayed R; El-Ela MA; El-Raziky MS; Helmy H; El-Ghaffar AA; El-Karaksy H
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):e267-70. PubMed ID: 21941130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.
    Zucker ML; Hagedorn CH; Murphy CA; Stanley S; Reid KJ; Skikne BS
    Int J Lab Hematol; 2012 Oct; 34(5):525-32. PubMed ID: 22708981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelets as a Gauge of Liver Disease Kinetics?
    Chen SH; Tsai SC; Lu HC
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions.
    Luther J; Friedman LS
    Clin Liver Dis; 2022 Feb; 26(1):1-12. PubMed ID: 34802655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets as Modulators of Liver Diseases.
    Lisman T; Luyendyk JP
    Semin Thromb Hemost; 2018 Mar; 44(2):114-125. PubMed ID: 28898899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.
    Misgav M; Shenkman B; Budnik I; Einav Y; Martinowitz U
    Anesth Analg; 2011 May; 112(5):1034-40. PubMed ID: 21474661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets in liver disease, cancer and regeneration.
    Kurokawa T; Ohkohchi N
    World J Gastroenterol; 2017 May; 23(18):3228-3239. PubMed ID: 28566882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure.
    Saab S; Bernstein D; Hassanein T; Kugelmas M; Kwo P
    J Clin Gastroenterol; 2020 Jul; 54(6):503-511. PubMed ID: 32195771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.
    Castillo R; Escolar G; Monteagudo J; Aznar-Salatti J; Reverter JC; Ordinas A
    Transfusion; 1997 Aug; 37(8):785-90. PubMed ID: 9280321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Disease and Hemostatic (Dys)function.
    Tripodi A
    Semin Thromb Hemost; 2015 Jul; 41(5):462-7. PubMed ID: 26080306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.